Hints and tips:
...One scoop to start: Private equity groups Warburg Pincus and Permira are preparing to list or sell wealth manager Tilney Smith & Williamson as they seek to exit their investment 18 months after a merger....
...Russia’s Sputnik V jab has shown 91.6 per cent efficacy against symptomatic Covid-19 in clinical trials, a Lancet peer review confirmed....
...Deloitte said one female partner, Nikki Mitchell, had recently been appointed as lead auditor of DS Smith....
...Bohuon joined the company in 2011 after stints at a number of pharmaceuticals groups including GlaxoSmithKline....
...Freemium v paid: Streaming competition swells YouTube is one of several Spotify competitors bringing streaming services to the market this year....
...“There is a real danger of that,” said Paul Smith, a Supreme Court specialist at the Jenner & Block law firm....
...Only five companies – Royal Dutch Shell, Vodafone, HSBC, GlaxoSmithKline and BP accounted for more than one-third of all the dividends paid, and just 15 made up almost three-fifths of the total....
...Sir Paul has given £5m to the V&A and £3m to the British Museum’s new medieval gallery....
...“The revenue raised was at the top end of our expectations,” said Nick Wenban-Smith, senior legal counsel for Nominet....
...GlaxoSmithKline was up 0.3 per cent at £11.87 after the US Food and Drug Administration approved its Benlysta treatment for lupus with no significant safety warnings on the label....
...Stacey Smith, head of men’s wear at Matches (www.matchesfashion.com), adds: “Chunky knits have certainly become more of a statement category.”...
...for NESV to become the new owners, but warns that if the club slips into administration it will be automatically docked nine points.Related link: Penalty fear over Liverpool fight October 12 2010 RBS v...
...“Our competitors get into these brand wars like Coke v Pepsi,” says Zimmer at UTA....
...David Smith, London TF: Around two-third of revenues from FTSE All Share companies are derived from outside the UK....
...When Roger Scarlett-Smith was first posted to Pittsburgh in the mid-1990s, his UK colleagues were quick to offer their condolences....
...GlaxoSmithKline is expanding into an area of medicine designed to slow the onset of ageing with the £362m acquisition of Sirtris Pharmaceuticals....
...In the pharmaceuticals sector, GlaxoSmithKline improved 0.5 per cent to £13.71....
...The Sunday Times Skyepharma is facing a rebellion by leading shareholders, including Fidelity and Insight Investment management, who are considering attempting to oust Ian Gowrie-Smith as chairman of the...
...Smith & Nephew scraps skin graft treatment Smith & Nephew is to axe its much-hyped skin graft product, after more than a decade of work and about £100m of investment....
...Smiths Group rose 1.7 per cent to 972½p as the aerospace company said 2005 profits would be slightly higher under the IFRS accounting standard....
...All eyes are on AstraZeneca (£40.5bn), the Anglo-Swedish group, which has long been rumoured as a target for larger rival GlaxoSmithKline....
...The NYSE-listed shares of AstraZeneca fell 8.6 per cent to $40.34 while GlaxoSmithKline's US-listed shares lost 3.22. Merck's stock saw limited action while Pfizer's was fractionally lower....
International Edition